Xu PP - Search Results

1

Positron emission tomography-adapted therapy in low-risk diffuse large B-cell lymphoma: results of a randomized, phase III, non-inferiority trial.

Shi Q, He Y, Yi HM, Mu RJ, Jiang XF, Fu D, Dong L, Qin W, Xu PP, Cheng S, Song Q, Chen SJ, Wang L, Zhao WL. Shi Q, et al. Among authors: xu pp. Cancer Commun (Lond). 2023 Aug;43(8):896-908. doi: 10.1002/cac2.12462. Epub 2023 Jul 4. Cancer Commun (Lond). 2023. PMID: 37403255 Free PMC article. Clinical Trial.

2

Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients.

Xu PP, Wang Y, Shen Y, Wang L, Shen ZX, Zhao WL. Xu PP, et al. Med Oncol. 2012 Sep;29(3):2176-82. doi: 10.1007/s12032-011-0011-0. Epub 2011 Jun 28. Med Oncol. 2012. PMID: 21710236

3

[Prognostic analysis of non-cytogenetic factors in elderly adults with acute myeloid leukemia].

Zhao BB, Zhu Z, Xu PP, Li JM, Shen ZX, Zhao WL, Wang L. Zhao BB, et al. Among authors: xu pp. Zhonghua Xue Ye Xue Za Zhi. 2013 Jan;34(1):3-7. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23597455 Chinese.

4

[Study of prognostic related factors of elderly patients with T/NK cell lymphoma].

Wang Y, Qian Y, Wu LL, Zhao BB, Xu PP, Zhao WL, Wang L. Wang Y, et al. Among authors: xu pp. Zhonghua Xue Ye Xue Za Zhi. 2013 Jan;34(1):12-5. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23597457 Chinese.

5

Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients.

Xu P, Yu D, Wang L, Shen Y, Shen Z, Zhao W. Xu P, et al. Ann Hematol. 2015 Feb;94(2):239-47. doi: 10.1007/s00277-014-2188-8. Epub 2014 Sep 6. Ann Hematol. 2015. PMID: 25193354

6

Clinical characteristics and prognostic factors of patients with mature T-cell lymphoid malignancies: a single-institution study of 225 cases.

Xue W, Sheng Y, Weng X, Zhu Y, Zhao Y, Xu P, Fei X, Chen X, Wang L, Zhao W. Xue W, et al. Front Med. 2015 Dec;9(4):468-77. doi: 10.1007/s11684-015-0419-6. Epub 2015 Nov 11. Front Med. 2015. PMID: 26559194

7

Induction of autophagy by valproic acid enhanced lymphoma cell chemosensitivity through HDAC-independent and IP3-mediated PRKAA activation.

Ji MM, Wang L, Zhan Q, Xue W, Zhao Y, Zhao X, Xu PP, Shen Y, Liu H, Janin A, Cheng S, Zhao WL. Ji MM, et al. Among authors: xu pp. Autophagy. 2015;11(12):2160-71. doi: 10.1080/15548627.2015.1082024. Autophagy. 2015. PMID: 26735433 Free PMC article.

8

Novel agent induction therapy alone or followed by autologous stem cell transplantation in younger patients with multiple myeloma: A single-center retrospective study of 114 cases.

Wang Y, Xu P, Chen Y, Fan Q, Li J, Zhao W, Mi J, Yan H. Wang Y, et al. Mol Clin Oncol. 2016 Jan;4(1):107-113. doi: 10.3892/mco.2015.658. Epub 2015 Oct 16. Mol Clin Oncol. 2016. PMID: 26870367 Free PMC article.

9

B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study.

Xu PP, Zhong HJ, Huang YH, Gao XD, Zhao X, Shen Y, Cheng S, Huang JY, Chen SJ, Wang L, Zhao WL. Xu PP, et al. EBioMedicine. 2017 Feb;16:106-114. doi: 10.1016/j.ebiom.2017.01.027. Epub 2017 Jan 21. EBioMedicine. 2017. PMID: 28153771 Free PMC article.

10

[Prognostic Significance of Follicular Lymphoma International Prognostic Index 2 (FLIPI2) in Follicular Lymphoma Patients Treated with Rituximab Maintenance].

Xu PP, Qian Y, Chen QS, Li LQ, Zhang L, Zhao WL. Xu PP, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Apr;25(2):426-430. doi: 10.7534/j.issn.1009-2137.2017.02.021. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017. PMID: 28446287 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters